Presentation is loading. Please wait.

Presentation is loading. Please wait.

Towards Equitable& Affordable Medicine Prices Policies in Jordan.

Similar presentations


Presentation on theme: "Towards Equitable& Affordable Medicine Prices Policies in Jordan."— Presentation transcript:

1 Towards Equitable& Affordable Medicine Prices Policies in Jordan

2 Strategies to overcome Over- dispensing and multiple dispensing to improve medicine availability Ministry of Health Health Insurance Department DR. AHMAD BARMAWI

3 Health Care Providers, Demographic and Health Data MOH RMS Universities Other ministries Private Sectors International and NGOs

4 Health Care Providers…….. (cont) MOH Peripheral H.C:243 Primary H.C:370 Comprehensive H.C:058 MCH406 Dental Clinics:274 Chest Diseases Clinics:012 Hospitals030

5 Health Care Providers …. (cont ) Population : 5,600,000 G.D.P (2006):JD10,108,500,000 Per Capita of GDP(2006)JD1,805 General Budget(2006)JD3,448,600,000 MOH Budget(2006)JD211,486, % of Total Budget Total Expenditure on Health:JD950,600,000 =9.8% of GDP Per Capita Health Care Exp:JD169

6 Health Care Providers…. (cont) Primary Health Care18.9% Secondary and tertiary 78.59% Administration and training2.51% Expenditure on Pharmaceuticals JD320,000,000 JD57 Per capita 33.6% of ( H.Exp. per capita) Public 18.5% Private 81.5% MOHJD30,000,000 CHIJD3,250,000 Expenditure on treatment abroadJD (insured)

7 Distribution of H.E. according to resources Total JD950,600, % MOH JD211,000,00022,2% Other public JD120,000,00012,6% Civil Health Insurance JD59,000,0006,2% Military H.I. JD30,100,0003,2% Private H.E JD530,000,00055,8%

8 Irrational use of Medicine in Jordan Over- dispensing Multiple dispensing Duplication of therapy Fraud Failure of adherence to treatment.

9 The Problem High Expenditure on pharmaceuticals Estimated Waste of medicine in Jordan JD90,000, % of Health Expenditure 28% of Exp.on pharmaceuticals Estimated Waste of medicine in MOH JD 9,300,000

10 Causes of irrational use of medicine Malpractices of prescribing by doctors Malpractices of dispensing by pharmacists Drug pricing policies and non ethical promotional activities of the pharmaceutical industry Lack of information and communication on rational drug use to providers and consumers Lack of effective control and regulatory mechanism on drug use Change in diseases prevalence and incidence patterns ( NCD, CD)

11 Stake holders Consumers Providers Ministry of Health JFDA Other Public Health Sector Private medical sector Professional associations Pharmaceutical industry Multinational pharmaceutical Companies

12 Promotion of Rational Drug use in Jordan A - JFDA strategic objectives and activities Promotion of JNDF&JRDL Printing and dissemination Increase awareness and importance of implementing RDU concept Promotion, support and monitor PTCs in public hospitals Increase awareness of prescribers, dispensers and pts. about drug use RDU news letters. Reinforce JNDF core teaching resource in medical and pharmacy curriculum Standardize the treatment for common diseases STGs

13 B- HID / MOH Previous Actions ٠Clinical guide lines- (NCD) Clinical treatment booklet (NCD) Pts. health education programs Control of drug representation and marketing Restriction of drug promotion by media Professional Committees: Non listed drugs Growth Hormones Respiratory Diseases drugs Monitoring adherence to NDL and substitutes Coordination with dept. of procurement for availability of essential medicines Encourage first choice treatment Control dispensing certain groups of medicine (narcotics)

14 C- Joint Drug Procurement administration Strategies to improve efficiency in medicine procurement Minimize zero- stock concept Limit waste and duplication Bar-coding inspection and control

15 Proposal Policy Extension Comprehensive STGs Training Programs( problem- based) Problem based – pharmacotherapy (STG) Licensure of health professions Paramedical education (STGs) National/Regional Drug information Centers Encourage consumer organizations involvement in public education about RDU Separate prescribing procedures from Dispensing Dispensing fees Price control on Generic and brand drugs

16 Proposal (cont) Medicine booklet Re imbursement limited to essential medicines Reference Prices National plan to enhance researches: Pre- clinical studies Clinical studies Pharmaceutical studies Studies to limit waste in the disbursement of medicines Control of drug representation and marketing Appropriate evidence –based Health system Evidence-based medicine Evidence – based practices and management.

17 Proposal (cont) Introducing active connecting system for exchange of information with health care providers to prevent duplication of medicine prescription

18 Important tools of Control **Smart card Hold Medical History and N. ld. No Prevents duplication of Medicine Minimize abuse and malpractice Medical audit Used by doctor or nurse Needs printer and reader Issue center and equipments Training

19 E. health E. Network E. Medical file form Access to other Health Sectors Access Medicine supply dept prescribing locations( hospitals, HC) balance of needs and distribution THANK YOU DR.A.BARMAWI

20 Title Title Title Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text text Text.


Download ppt "Towards Equitable& Affordable Medicine Prices Policies in Jordan."

Similar presentations


Ads by Google